Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People Briefs: CEO At LifeScience Alley; Orthofix, Exact Sciences Appoint Board Chairs

This article was originally published in The Gray Sheet

Executive Summary

LifeScience Alley CEO Dale Wahlstrom retires and Shaye Mandle named successor. Orthofix International and Exact Sciences name new board chairs. Wound Management appoints new CFO, director of R&D and chief medical officer. Other people news.

You may also be interested in...



People Briefs: Covidien CFO To Retire; Appointments At ConvaTec, Metamark, NeuroSigma, Uroplasty

Covidien Chief Financial Officer Charles Dockendorff announces retirement. ConvaTec, Metamark, NeuroSigma and Uroplasty appoint executives. More people briefs.

Medical Device Innovation Consortium Sets Priorities To Advance Reg Science

The heads of the newly formed private-public partnership comprising industry, academia and FDA describe the group’s top three projects to advance medical device regulatory science.

People In Brief

Colibri Heart Valve CEO

Topics

Related Companies

UsernamePublicRestriction

Register

MT032848

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel